Obesity might be a very modern problem, but a team of scientists from Taiwan and China is turning to the age-old principles of traditional Chinese medicine (TCM) to help fight it. Breaking research published in the Journal ...
Jan 31, 2013
0
0
Women with polycystic ovary syndrome (PCOS) who are taking combined oral contraceptives have a 2-fold risk of blood clots compared with women without the disorder who take contraceptives, states a study published in CMAJ ...
Dec 3, 2012
0
1
The FDA says baby bottles and sippy cups can no longer contain Bisphenol-A (BPA), an endocrine disruptor that mimics estrogen. But what about the hundreds of other plastic items, from water bottles to dental sealants, containing ...
Jul 23, 2012
0
0
A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of this endocrine disorder ever conducted. Results of the clinical trial conducted ...
Mar 7, 2012
0
0
A new study from the University of Adelaide shows the parents of women with polycystic ovary syndrome (PCOS) are more likely to have some form of cardiovascular disease.
Oct 5, 2011
0
1
Denmark's Novo Nordisk, the world's leading insulin maker, said Thursday it will buy US-based Dicerna Pharmaceuticals, a developer of RNA interference technology which targets genes that cause disease.
Nov 18, 2021
0
1
The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid, showed that adding the cyclin-dependent kinase (CDK) 4/6 inhibitor abemaciclib to endocrine therapy improved progression-free survival compared ...
Sep 11, 2017
0
1
Binge-eating disorder (BED) was linked with a broad range of other illnesses in a recent study, with the strongest associations related to the endocrine and circulatory systems.
Sep 19, 2016
0
2
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher ...
Jun 24, 2013
0
0
The addition of zoledronic acid to adjuvant endocrine therapy increased bone mineral density and reduced the risk for disease recurrence among postmenopausal women with early hormone receptor-positive breast cancer, according ...
Dec 7, 2011
0
0
